One-on-One with Dan Adelman of Alvine Pharmaceuticals

One-on-One with Dan Adelman of Alvine Pharmaceuticals

November 18, 2011

A gluten-free diet is great for celiac disease patients, but even the strictest adherents to dietary restrictions can experience flare ups or chronic symptoms.
 
That’s where Alvine Pharmaceuticals Inc.  .. comes in with a drug that could make a huge impact. The San Carlos company earlier this month reported results of a Phase IIa trial that showed that its drug, ALV-003, could make a difference in helping patients with gluten-limiting celiac disease. It is the first mid-stage study to get positive results in modulating the immune system’s response to the storage protein.

Click on San Fransisco Business Times logo to view full article